The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Left or biventricular dysfunction/failure
Publications
A rare case of cardiac toxicity in a patient with imatinib treatment: Case report.
Journal of cancer research and therapeutics 2022 Apr-Jun;18;792-794 — 2022 Apr-Jun — 792-794
Imatinib-induced decompensated heart failure in an elderly patient with chronic myeloid leukemia: case report and literature review.
Journal of geriatric cardiology : JGC 2012 Dec;9;411-4 — 2012 Dec — 411-4
Is imatinib-related cardiotoxicity still an open issue?
Leukemia research 2011 Jan;35;34-5 — 2011 Jan — 34-5